Jane Huang

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Camana Bay
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Mary Grendell, Attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jane Huang

Form 4 holding CMO, Hematology

BeiGene, Ltd.

Security class
Ordinary Shares
Shares / value
160,055
Estimated value
$33,246,160
Report date
14 Dec 2021
Price
$207.72
Ownership
Direct
Form 4 holding President, CMO

Prelude Therapeutics Inc

Security class
Restricted Stock Unit
Shares / value
18,750
Estimated value
$25,969
Report date
04 Oct 2025
Price
$0.6925
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CMO, Hematology

BeiGene, Ltd.

Security class
Share Option (Right to Buy)
Shares / value
211,276
Estimated value
Report date
14 Dec 2021
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding President, CMO

Prelude Therapeutics Inc

Security class
Employee Stock Option (right to buy)
Shares / value
200,000
Estimated value
Report date
04 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CMO, Hematology

BeiGene, Ltd.

Security class
American Depositary Shares
Shares / value
0
Estimated value
Report date
14 Dec 2021
Price
$180.50
Ownership
Direct

Insider Reports Filed by Jane Huang

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .